The interferon-inducible transmembrane (IFITM) protein family represents a new class of
cellular restriction factors that block early stages of viral replication; the underlying mechanism …

SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic, infecting
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …

The development of a protective vaccine remains a top priority for the control of the HIV/AIDS
pandemic. Here, we show that a messenger RNA (mRNA) vaccine co-expressing …

The interfacial Dzyaloshinskii-Moriya interaction (DMI) in multilayers of heavy metal and
ferromagnetic metals enables the stabilization of novel chiral spin structures such as skyrmions. …

HIV-1 envelope glycoproteins (Env) represent the only virus-specific antigen exposed at the
surface of infected cells. In its unliganded form, Env from primary viruses samples a ‘closed' …

The interferon-inducible myxovirus resistance (Mx) proteins play important roles in combating
a wide range of virus infections. MxA inhibits many RNA and DNA viruses, whereas the …

Neutralizing antibodies (NAbs) are effective in treating COVID-19, but the mechanism of
immune protection is not fully understood. Here, we applied live bioluminescence imaging (BLI) …

Emerging evidence indicates that both neutralizing and Fc-mediated effector functions of
antibodies contribute to protection against SARS-CoV-2. It is unclear whether Fc-effector …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) mediates viral
entry into cells and is critical for vaccine development against coronavirus disease 2019 (…

Emerging variants of concern for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
can transmit more efficiently and partially evade protective immune responses, …